MedTrace Logo

Swiss TrAumatic biRth Trial

NCT03576586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2022-08-17

No results posted yet for this study

Summary

This randomized controlled study aims to investigate the effects of a brief computerized intervention (the computer game "Tetris") on intrusive memories and other posttraumatic stress symptoms following an emergency cesarean section (ECS). Women who have undergone an emergency cesarian section will be randomly allocated to either the brief computerized intervention plus usual care or an attention placebo control group plus usual care within the first 6 hours following the ECS. Women and their infants will be followed up at ≤ 1 week postpartum, 6 weeks postpartum, and 6 months postpartum. It is predicted that women given the brief computerized intervention will develop fewer intrusive memories and less posttraumatic stress symptoms than those who are not. This will inform the development of a simple computerized early intervention to prevent distressing psychological symptoms after a traumatic event, such as an ECS.

Conditions

Interventions

BEHAVIORAL

Brief computerized intervention

Brief computerized intervention (computer game "Tetris") plus usual care in the maternity department

BEHAVIORAL

Attention placebo control

Brief cognitive task plus usual care in the maternity department

Sponsors & Collaborators

  • University of Lausanne

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • University of Fribourg

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Antje Horsch, D.Clin.Psych. · University of Lausanne and Lausanne University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-02
Primary Completion
2021-12-15
Completion
2022-02-08

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03576586 on ClinicalTrials.gov